Sign in

CIK 0001553643

  • Non-accelerated filer
  • Smaller reporting company

RELMADA THERAPEUTICS, INC.

Sign in to watch
Ticker
RLMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
455401931
Phone
+1 646-876-3459
Business address
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
Former names
CAMP NINE, INC.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Director sold 10,000 shares at $30.04 ($300,395)
  4. 4 Open-market sale Director sold 19,800 shares at $29.00 ($574,200)
  5. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Director sold 6,600 shares at $29.00 ($191,400)
  14. 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
  15. 4 Open-market sale Director sold 3,300 shares at an average $31.54 ($104,088)
  16. 4/A Insider Changes in Ownership
  17. 4 Open-market sale Director sold 3,000 shares at an average $33.34 ($100,020)
  18. 4 Open-market sale Director sold 3,000 shares at $38.22 ($114,647)
  19. 4 Open-market sale Director sold 3,000 shares at an average $35.43 ($106,281)
  20. 4 Open-market sale CEO sold 10,000 shares at an average $35.48 ($354,845)

Page 5 of 10 · 200 filings